ctrl K

Cadrenal Therapeutics Inc... (CVKD)

NASDAQ: CVKD · Real-Time Price · USD

16.70

0.20 (1.21%)

At close: May 02, 2025, 11:44 AM

Cadrenal Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	10.02M	8.4M	32.59K
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	3.79K	3.79K	-526.01K
Receivables	38.15K	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	14.45K	n/a	672.29K
Total Current Assets	10.11M	8.49M	727.6K
Property-Plant & Equipment	6.94K	23.29K	44.59K
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	10.74K	27.08K	50.58K
Total Assets	10.12M	8.52M	778.17K
Account Payables	1.5M	167.32K	404.9K
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	43.73K
Other Current Liabilities	1.18M	596.13K	605.29K
Total Current Liabilities	2.68M	826.88K	1.33M
Long-Term Debt	n/a	n/a	553.34K
Other Long-Term Liabilities	n/a	n/a	4.42M
Total Long-Term Liabilities	n/a	n/a	4.99M
Total Liabilities	2.68M	826.88K	6.33M
Total Debt	n/a	21.35K	640.71K
Common Stock	1.78K	13.02K	8.19K
Retained Earnings	-25.72M	-15.07M	-6.71M
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	7.44M	7.69M	-5.55M
Total Investments	n/a	n/a	n/a